You just read:

Array BioPharma Announces Publication of Detailed Phase 3 COLUMBUS Trial Data of Encorafenib and Binimetinib in Melanoma Patients in The Lancet Oncology

News provided by

Array BioPharma

Mar 22, 2018, 09:00 ET